In an MDA-MB-468 heterogeneous tumor comprizing HER2-GFP positive cells and CD33-DsRed cells, time-lapse images clearly demonstrated the specific tumor killing by Fabrack T cells in the presence of a corresponding memAb and capability of Fabrack T cells to eradicate a heterogeneous tumor. This evidence concerns the gene CD33 and neoplasm.